These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20445199)

  • 21. Trends in Modern Drug Discovery.
    Eder J; Herrling PL
    Handb Exp Pharmacol; 2016; 232():3-22. PubMed ID: 26330257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The path from bench to bedside: considerations before starting the journey.
    Freeman MW; Dervan AP
    J Investig Med; 2011 Jun; 59(5):746-51. PubMed ID: 21441830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of academic institutions in the development of drugs for rare and neglected diseases.
    Coles LD; Cloyd JC
    Clin Pharmacol Ther; 2012 Aug; 92(2):193-202. PubMed ID: 22760003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
    Litten RZ; Ryan M; Falk D; Fertig J
    Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical industry, academia and patient advocacy organizations: what is the recipe for synergic (win-win-win) collaborations?
    Rose DM; Marshall R; Surber MW
    Respirology; 2015 Feb; 20(2):185-91. PubMed ID: 25580960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Innovative Medicines Initiative: an engine for regulatory science.
    Goldman M; Seigneuret N; Eichler HG
    Nat Rev Drug Discov; 2015 Jan; 14(1):1-2. PubMed ID: 25503331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons from a Recovering Academic.
    Ehlers MD
    Cell; 2016 May; 165(5):1043-1048. PubMed ID: 27203106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing roles of industry and academia.
    Bauer EA; Cohen DE
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational research: the changing landscape of drug discovery.
    Fishburn CS
    Drug Discov Today; 2013 May; 18(9-10):487-94. PubMed ID: 23247258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Academic drug discovery: current status and prospects.
    Everett JR
    Expert Opin Drug Discov; 2015; 10(9):937-44. PubMed ID: 26088126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicines discovery in the 21st century: the case for a stakeholder corporation.
    Dixon J; England P; Lawton G; Machin P; Palmer A
    Drug Discov Today; 2010 Sep; 15(17-18):700-3. PubMed ID: 20678583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 35. Large drug firms narrow their therapeutic interests.
    Mullard A
    Lancet; 2014 May; 383(9932):1873. PubMed ID: 24892171
    [No Abstract]   [Full Text] [Related]  

  • 36. The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution.
    Stegemann S
    Eur J Pharm Sci; 2016 Jul; 90():8-13. PubMed ID: 26542345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to Alzheimer disease drug discovery and development in academia.
    Van Eldik LJ; Koppal T; Watterson DM
    Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S18-28. PubMed ID: 12070358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Precompetitive research: a new prescription for drug development?
    Woodcock J
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract]   [Full Text] [Related]  

  • 39. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 40. Open innovation: the new face of pharmaceutical research and development.
    Getz KA; Kaitin KI
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):481-3. PubMed ID: 23121265
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.